Skip to main content

Vident Advisory, LLC

SEC CIK
0001744347
Latest filing
Aug 12, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Vident Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q3 2024)
0
Sold out in Q3 2024
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q3 2023
Holdings of CRSP by Vident Advisory, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20240$00.0%−14,104−100.0%Sold outHolders
Q2 202414,104$761.7K<0.1%+61+0.4%AddedHolders
Q1 202414,043$957.2K<0.1%+3,561+34.0%AddedHolders
Q4 202310,482$656.2K<0.1%+357+3.5%AddedHolders
Q3 202310,125$459.6K<0.1%–No prior filingHolders